Skip to main content
construction release_alert
The Scholars Team is working with OIT to resolve some issues with the Scholars search index
cancel

Sin-Ho Jung

Professor of Biostatistics & Bioinformatics
Biostatistics & Bioinformatics, Division of Integrative Genomics
Duke Box 2721, Durham, NC 27710
2424 Erwin Road Ste 1102, 11076 Hock Plaza, Durham, NC 27705-3858

Overview


Design of Clinical Trials
Survival Analysis
Longitudinal Data Analysis
Clustered Data Analysis
ROC Curve Analysis
Design and Analysis of Microarray Studies
Big Data Analysis

Current Appointments & Affiliations


Professor of Biostatistics & Bioinformatics · 2006 - Present Biostatistics & Bioinformatics, Division of Integrative Genomics, Biostatistics & Bioinformatics
Member of the Duke Cancer Institute · 2021 - Present Duke Cancer Institute, Institutes and Centers

Recent Publications


Low intensity focused ultrasound stimulation in stroke: A phase I safety & feasibility trial.

Journal Article Brain Stimul · 2025 OBJECTIVE: We aimed to determine the maximum safe spatial-peak pulse-average intensity (ISPPA) of low-intensity focused ultrasound stimulation (LIFUS) in stroke patients and explore its effect on motor learning and corticospinal excitability. METHODS: We a ... Full text Link to item Cite

Randomized Phase II Cancer Clinical Trials to Validate Predictive Biomarkers.

Journal Article Biomedicines · September 26, 2024 OBJECTIVES: The design of cancer clinical trials incorporating biomarkers depends on various factors, including the trial phase, the type of biomarker and whether its role has been validated. This article aims to present a method for designing and analyzin ... Full text Link to item Cite

A Dunnett-Type Test and Its Sample Size Calculation for Comparing K ROC Curves with a Control.

Journal Article Diagnostics (Basel, Switzerland) · August 2024 Diagnostic biomarkers are key components of diagnostics. In this paper, we consider diagnostic biomarkers taking continuous values that are associated with a dichotomous disease status, called malignant or benign. The performance of such a biomarker is eva ... Full text Cite
View All Publications

Education, Training & Certifications


University of Wisconsin, Madison · 1992 Ph.D.